Fulgent Genetics (FLGT) Change in Accured Expenses (2016 - 2026)
Fulgent Genetics' Change in Accured Expenses history spans 12 years, with the latest figure at -$2.1 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 71.64% to -$2.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $14.3 million, a 302.14% increase, with the full-year FY2025 number at $8.9 million, up 324.97% from a year prior.
- Change in Accured Expenses hit -$2.1 million in Q1 2026 for Fulgent Genetics, down from $12.3 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for FLGT hit a ceiling of $12.3 million in Q4 2025 and a floor of -$13.2 million in Q3 2022.
- Historically, Change in Accured Expenses has averaged -$315882.4 across 5 years, with a median of -$177000.0 in 2023.
- Biggest five-year swings in Change in Accured Expenses: crashed 932.2% in 2024 and later soared 1862.58% in 2025.
- Tracing FLGT's Change in Accured Expenses over 5 years: stood at $2.0 million in 2022, then soared by 423.32% to $10.4 million in 2023, then crashed by 93.97% to $628000.0 in 2024, then soared by 1862.58% to $12.3 million in 2025, then crashed by 117.23% to -$2.1 million in 2026.
- Business Quant data shows Change in Accured Expenses for FLGT at -$2.1 million in Q1 2026, $12.3 million in Q4 2025, and -$1.1 million in Q3 2025.